We found that the NEK1+/+ parental TRAMP mouse developed PRAD (Figure 5B) even after castration, whereas the NEK1+/−-TRAMP mouse castrated at 12 weeks did not progress from PIN and hyperplasia to overt PRAD and CRPC. This evidence concerns the gene NEK1 and prostate adenocarcinoma.